AIM: £41.50 (-0.7) | Nasdaq: $26.97 (+0.22)

Search

EN
简
繁

About Us
Innovation Platform
Commercial Platform
News & Presentations
Leadership & Governance
Financial Results
Shareholder Information

About Us
Innovation Platform

Overview
Our Pipeline
R&D Approach
Key Corporate Partnerships
Innovation News

Commercial Platform

Overview
Prescription Drugs
Competitive Advantages
Main Products
Consumer Health
Commercial Platform News

News & Presentations

Recent News
All RNS & Press Releases
Presentations & Publications

Leadership & Governance

Our Leadership
Board of Directors
Senior Management
Corporate Information
Terms of Reference & Policies

Financial Results

Overview
Financial Highlights
Chairman's Statement
Financial Reports
SEC Filings

Shareholder Information

Overview
Share Price & Chart
Major Shareholders
Events, Circulars & Forms
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Warning to Shareholders
AIM Rule 26

Site map

Chi-Med
| Site map

About Us

Our Vision and Strategy

Innovation Platform

R&D Approach
Elunate Launch Event
Our Pipeline
Key Corporate Partnerships

Commercial Platform

Prescription Drugs
Competitive Advantages
Main Products
Consumer Health

Announcements and Presentations

All RNS Announcements
Key Announcements
RNS Regulatory Notices
Presentations

和黄中国医药科技有限公司

Leadership & Governance

Board of Directors
Senior Management
Corporate Information
Terms of Reference & Policies

Financial Information

SEC Filings
Financial Highlights
Chairman's Statement
Financial Reports

Shareholder Information

Share Price & Chart
Major Shareholders
Events, Circulars & Forms
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Warning to Shareholders
AIM Rule 26

和黄中国医药科技有限公司

和黄中国医药科技有限公司
和黄中国
和黄中国医药科
和黄中国医药科技
和黄医药
和黄医药科技

Contact Us
Disclaimer
Privacy Policy

© 2019 Hutchison China MediTech Limited